Literature DB >> 24831540

The zinc finger transcription factor ZFX is required for maintaining the tumorigenic potential of glioblastoma stem cells.

Xiaoguang Fang1, Zhi Huang, Wenchao Zhou, Qiulian Wu, Andrew E Sloan, Gaoliang Ouyang, Roger E McLendon, Jennifer S Yu, Jeremy N Rich, Shideng Bao.   

Abstract

Glioblastomas are highly lethal brain tumors containing tumor-propagating glioma stem cells (GSCs). The molecular mechanisms underlying the maintenance of the GSC phenotype are not fully defined. Here we demonstrate that the zinc finger and X-linked transcription factor (ZFX) maintains GSC self-renewal and tumorigenic potential by upregulating c-Myc expression. ZFX is differentially expressed in GSCs relative to non-stem glioma cells and neural progenitor cells. Disrupting ZFX by shRNA reduced c-Myc expression and potently inhibited GSC self-renewal and tumor growth. Ectopic expression of c-Myc to its endogenous level rescued the effects caused by ZFX disruption, supporting that ZFX controls GSC properties through c-Myc. Furthermore, ZFX binds to a specific sequence (GGGCCCCG) on the human c-Myc promoter to upregulate c-Myc expression. These data demonstrate that ZFX functions as a critical upstream regulator of c-Myc and plays essential roles in the maintenance of the GSC phenotype. This study also supports that c-Myc is a dominant driver linking self-renewal to malignancy.
© 2014 AlphaMed Press.

Entities:  

Keywords:  Cancer stem cell; Glioblastoma; Self-renewal; Tumorigenesis; Zinc finger and X-linked transcription factor; c-Myc

Mesh:

Substances:

Year:  2014        PMID: 24831540      PMCID: PMC4349564          DOI: 10.1002/stem.1730

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  56 in total

1.  Zfx controls the self-renewal of embryonic and hematopoietic stem cells.

Authors:  Jose M Galan-Caridad; Sivan Harel; Teresita L Arenzana; Z Esther Hou; Fiona K Doetsch; Leonid A Mirny; Boris Reizis
Journal:  Cell       Date:  2007-04-20       Impact factor: 41.582

2.  Targeting cancer stem cells through L1CAM suppresses glioma growth.

Authors:  Shideng Bao; Qiulian Wu; Zhizhong Li; Sith Sathornsumetee; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 3.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

4.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

5.  Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.

Authors:  Tatyana N Ignatova; Valery G Kukekov; Eric D Laywell; Oleg N Suslov; Frank D Vrionis; Dennis A Steindler
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

6.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

Review 7.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

8.  The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.

Authors:  Bryan King; Thomas Trimarchi; Linsey Reavie; Luyao Xu; Jasper Mullenders; Panagiotis Ntziachristos; Beatriz Aranda-Orgilles; Arianne Perez-Garcia; Junwei Shi; Christopher Vakoc; Peter Sandy; Steven S Shen; Adolfo Ferrando; Iannis Aifantis
Journal:  Cell       Date:  2013-06-20       Impact factor: 41.582

9.  ZFX controls the self-renewal of human embryonic stem cells.

Authors:  Sivan Harel; Edmund Y Tu; Stuart Weisberg; Manuel Esquilin; Stuart M Chambers; Becky Liu; Christian T Carson; Lorenz Studer; Boris Reizis; Mark J Tomishima
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

10.  Zfx mutation results in small animal size and reduced germ cell number in male and female mice.

Authors:  S W Luoh; P A Bain; R D Polakiewicz; M L Goodheart; H Gardner; R Jaenisch; D C Page
Journal:  Development       Date:  1997-06       Impact factor: 6.868

View more
  25 in total

1.  Purine synthesis promotes maintenance of brain tumor initiating cells in glioma.

Authors:  Xiuxing Wang; Kailin Yang; Qi Xie; Qiulian Wu; Stephen C Mack; Yu Shi; Leo J Y Kim; Briana C Prager; William A Flavahan; Xiaojing Liu; Meromit Singer; Christopher G Hubert; Tyler E Miller; Wenchao Zhou; Zhi Huang; Xiaoguang Fang; Aviv Regev; Mario L Suvà; Tae Hyun Hwang; Jason W Locasale; Shideng Bao; Jeremy N Rich
Journal:  Nat Neurosci       Date:  2017-03-27       Impact factor: 24.884

2.  Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.

Authors:  Yu Shi; Wenchao Zhou; Lin Cheng; Cong Chen; Zhi Huang; Xiaoguang Fang; Qiulian Wu; Zhicheng He; Senlin Xu; Justin D Lathia; Yifang Ping; Jeremy N Rich; Xiu-Wu Bian; Shideng Bao
Journal:  Cell Death Differ       Date:  2016-10-14       Impact factor: 15.828

3.  EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.

Authors:  E Sanpaolo; M Miroballo; S Corbetta; C Verdelli; F Baorda; T Balsamo; P Graziano; F P Fabrizio; L Cinque; A Scillitani; L A Muscarella; Vito Guarnieri
Journal:  Endocrine       Date:  2016-02-15       Impact factor: 3.633

4.  Zinc finger protein X-linked is overexpressed in colorectal cancer and is associated with poor prognosis.

Authors:  Jin Jiang; Lu-Ying Liu
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

Review 5.  Cancer stem cells: a potential target for cancer therapy.

Authors:  Hong Qiu; Xiaoguang Fang; Qi Luo; Gaoliang Ouyang
Journal:  Cell Mol Life Sci       Date:  2015-05-13       Impact factor: 9.261

Review 6.  Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications.

Authors:  Tamara J Abou-Antoun; James S Hale; Justin D Lathia; Stephen M Dombrowski
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

7.  MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.

Authors:  Xiuxing Wang; Zhi Huang; Qiulian Wu; Briana C Prager; Stephen C Mack; Kailin Yang; Leo J Y Kim; Ryan C Gimple; Yu Shi; Sisi Lai; Qi Xie; Tyler E Miller; Christopher G Hubert; Anne Song; Zhen Dong; Wenchao Zhou; Xiaoguang Fang; Zhe Zhu; Vaidehi Mahadev; Shideng Bao; Jeremy N Rich
Journal:  Cancer Res       Date:  2017-07-20       Impact factor: 12.701

8.  Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.

Authors:  Fan Yang; Hongzhi Ma; Ling Feng; Meng Lian; Ru Wang; Erzhong Fan; Jugao Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 9.  Cancer stem cells in glioblastoma.

Authors:  Justin D Lathia; Stephen C Mack; Erin E Mulkearns-Hubert; Claudia L L Valentim; Jeremy N Rich
Journal:  Genes Dev       Date:  2015-06-15       Impact factor: 11.361

10.  Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.

Authors:  Yayoi Yoshimura; Akihiko Shiino; Kazue Muraki; Tadateru Fukami; Shigeki Yamada; Takeshi Satow; Miyuki Fukuda; Masaaki Saiki; Masato Hojo; Susumu Miyamoto; Nobuyuki Onishi; Hideyuki Saya; Toshiro Inubushi; Kazuhiko Nozaki; Kenji Tanigaki
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.